Timber Pharmaceuticals, Inc.

TMBR · AMEX
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
1/31/2020
Operating Activities
Net Income-$19,379-$10,639-$15,118-$3,645
Dep. & Amort.$327$273$117$0
Deferred Tax$0-$38$38$0
Stock-Based Comp.$1,049$636$219$89
Change in WC$327$438-$946$0
Other Non-Cash$1,821$16$7,397$2,417
Operating Cash Flow-$15,855-$9,314-$8,293-$1,228
Investing Activities
PP&E Inv.-$7-$18-$750$0
Net Acquisitions$0$0$341$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$7$0-$2,250-$384
Investing Cash Flow-$7-$18-$2,659-$384
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$7,990$15,792$17,500$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$8,134$15,792$21,244$1,680
Financing Cash Flow$8,134$15,792$21,244$1,680
Forex Effect$0$0$0$0
Net Chg. in Cash-$7,728$6,460$10,292$68
Supplemental Information
Beg. Cash$16,809$10,349$57$0
End Cash$9,080$16,809$10,349$68
Free Cash Flow-$15,862-$9,332-$9,043-$1,228